Organoid Technology_Galatek

Organoids are three-dimensional tissue analogs created in vitro using adult or pluripotent stem cells. They are designed to replicate both the structure and function of real organs, including their pathophysiological processes. Utilizing the advanced MegaLab3.0 platform, we have accelerated the development of organoids and integrated AI to optimize our experimental procedures. This approach has significantly improved the success rate of organoid culture. Galatek offers a efficient and stable organoid kit that includes a complete medium, basal medium, primary tissue storage solution, primary tissue digestion solution, growth factors, small molecules, and more.

Galatek Matrigel is made from the extracellular matrix components of mice tumor tissues. Its main components include laminin, collagen IV, and heparan sulfate proteoglycans. Galatek Matrigel also contains a variety of growth factors, such as epidermal growth factor (EGF), platelet-derived growth factor (PDGF), nerve growth factor (NGF), basic fibroblast growth factor (FGF-2), transforming growth factor beta (TGF-β), and insulin-like growth factor (IGF).

Galatek uses an advanced automation platform to facilitate high-throughput gene knockout technology. This technology precisely introduces mutations or deletes specific segments of genes in the genome, effectively inhibiting the expression and function of the target genes. Our highly experienced research team is dedicated to optimizing the gene editing process, which helps reduce research and development costs and experimental timelines for knockout cell lines. This ultimately provides researchers with an efficient and cost-effective tool for studying gene function.